total-news-1024x279-1__1_-removebg-preview.png

California moves to cap insulin cost at $30

California Gov. Gavin Newsom, a Democrat, announced Saturday that the state will manufacture its own insulin, capping the cost at $30.

CalRx in California Initiative It has partnered with nonprofit generic drug maker CIVICA to make the drug and cut prices by about 90%, according to the governor’s office.

“California will make the most affordable insulin in America. The new CalRx insulin is only $30. It will be available to all Californians and nationwide,” Newsom said. I’m here. Said on Twitter.

movement is presidential decree Newsom signed on his first day in office in 2019 with the goal of lowering the cost of prescription drugs.

“It costs $30 to manufacture and distribute, but that’s what consumers can afford. You don’t need a voucher or coupon to access this price, and it’s available to anyone, regardless of insurance plan.” release From the governor’s office detailing the plan.

But it’s still a while before low-cost drugs hit store shelves – governor’s office Said On that date, CIVICA and the California Department of Health and Human Services are still working together to identify potential manufacturing facilities within the state.

Newsom also announced on Saturday that states would next move to manufacture their own naloxone, a drug used to counteract the effects of opioid overdoses.

President Biden reiterated last week the administration’s focus on cutting healthcare spending, including high-cost insulin.

Pharmaceutical company Eli Lilly announced earlier this month that it was cutting the list price of its most popular insulin product by 70%, capping out-of-pocket costs to $35 a month. This was followed by similar moves from Novo Nordisk and Sanofi under increasing pressure. to a pharmaceutical company. lower their prices.

Copyright 2023 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Leave a Reply

Your email address will not be published. Required fields are marked *

Facebook
Twitter
LinkedIn
Reddit
Telegram
WhatsApp